Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2026-01-05 @ 1:27 AM
Study NCT ID:
NCT04822818
Status:
COMPLETED
Last Update Posted:
2022-12-28
First Post:
2021-03-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-11
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-25
First Submit QC Date:
None
Study First Post Date:
2021-03-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-26
Last Update Post Date:
2022-12-28
Last Update Post Date Type:
ACTUAL